Centric Medical Gains FDA 510(k) Clearance of Subtalar Arthroereisis Implant
Centric Medical received FDA 510(k) clearance to market the Subtalar Arthroereisis Implant to treat hyperpronation of the foot and support stabilization of the subtalar joint. Limited release will occur at the end of 2016, with full launch following in 1Q17.
This is the fourth 510(k) clearance in a year for Centric Medical, and one of 17 patents pending in its portfolio that includes the TARSA-LINK™ Stand-Alone Wedge Fixation System.
Sources: Centric Medical, ORTHOWORLD Inc.